Stilnox Treatment in Elderly Patients With Insomnia
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Primary objective:
1. To evaluate the efficacy of Zolpidem 5mg for 1 week in elderly patients with insomnia in
China
Secondary objectives:
1. To evaluate the safety of Zolpidem 5mg for 3 weeks in elderly patients with insomnia in
China.
2. To evaluate the efficacy of Zolpidem 5mg for 3 weeks in elderly patients with insomnia
in China